These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 11902809)
1. Simvastatin and lovastatin, but not pravastatin, interact with MDR1. Sakaeda T; Takara K; Kakumoto M; Ohmoto N; Nakamura T; Iwaki K; Tanigawara Y; Okumura K J Pharm Pharmacol; 2002 Mar; 54(3):419-23. PubMed ID: 11902809 [TBL] [Abstract][Full Text] [Related]
2. Interaction of digoxin with antihypertensive drugs via MDR1. Takara K; Kakumoto M; Tanigawara Y; Funakoshi J; Sakaeda T; Okumura K Life Sci; 2002 Feb; 70(13):1491-500. PubMed ID: 11895100 [TBL] [Abstract][Full Text] [Related]
3. Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport. Sakaeda T; Fujino H; Komoto C; Kakumoto M; Jin JS; Iwaki K; Nishiguchi K; Nakamura T; Okamura N; Okumura K Pharm Res; 2006 Mar; 23(3):506-12. PubMed ID: 16388406 [TBL] [Abstract][Full Text] [Related]
4. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861 [TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783 [TBL] [Abstract][Full Text] [Related]
6. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs. Kakumoto M; Takara K; Sakaeda T; Tanigawara Y; Kita T; Okumura K Biol Pharm Bull; 2002 Dec; 25(12):1604-7. PubMed ID: 12499648 [TBL] [Abstract][Full Text] [Related]
7. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes. Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. Newman A; Clutterbuck RD; Powles RL; Catovsky D; Millar JL Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443 [TBL] [Abstract][Full Text] [Related]
9. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307 [TBL] [Abstract][Full Text] [Related]
10. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225 [TBL] [Abstract][Full Text] [Related]
11. Interaction of docetaxel ("Taxotere") with human P-glycoprotein. Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657 [TBL] [Abstract][Full Text] [Related]
12. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs. Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169 [TBL] [Abstract][Full Text] [Related]
13. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. Serajuddin AT; Ranadive SA; Mahoney EM J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703 [TBL] [Abstract][Full Text] [Related]
14. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein. Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713 [TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Wang E; Casciano CN; Clement RP; Johnson WW Pharm Res; 2001 Jun; 18(6):800-6. PubMed ID: 11474784 [TBL] [Abstract][Full Text] [Related]
16. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. Chen C; Mireles RJ; Campbell SD; Lin J; Mills JB; Xu JJ; Smolarek TA Drug Metab Dispos; 2005 Apr; 33(4):537-46. PubMed ID: 15616150 [TBL] [Abstract][Full Text] [Related]
17. [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells]. Kunitama M; Komatsu N; Miura Y Rinsho Ketsueki; 1996 Nov; 37(11):1314-7. PubMed ID: 8960668 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells. Oi S; Haneda T; Osaki J; Kashiwagi Y; Nakamura Y; Kawabe J; Kikuchi K Eur J Pharmacol; 1999 Jul; 376(1-2):139-48. PubMed ID: 10440099 [TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479 [TBL] [Abstract][Full Text] [Related]
20. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle. van Vliet AK; Nègre-Aminou P; van Thiel GC; Bolhuis PA; Cohen LH Biochem Pharmacol; 1996 Nov; 52(9):1387-92. PubMed ID: 8937448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]